Oxford Biotherapeutics (United Kingdom)
Developing First-in-Class Cancer Therapies | Oxford BioTherapeutics
At Oxford BioTherapeutics, we are dedicated to pioneering the next generation of oncology treatments through targeted therapies, including Antibody-Drug Conjugates (ADC), Immuno-oncology, T-Cell Engagers (TCE), and radiopharmaceuticals.
Company details
- Address
- United Kingdom
- Website
- oxfordbiotherapeutics.com
Reviews
No reviews yet.
All reviews of Oxford Biotherapeutics (United Kingdom) · Write a review
Domain and WHOIS record
- Domain
- oxfordbiotherapeutics.com
- Registrar
- Register SPA
- Registered
- 19 Aug 2008
- Expires
- 19 Aug 2034
- Record updated
- 11 May 2026
- Name servers
- ns0.phase8.net, ns1.phase8.net, ns2.phase8.net
- DNSSEC
- Not signed